Spots Global Cancer Trial Database for stage iv laryngeal cancer
Every month we try and update this database with for stage iv laryngeal cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck Cancer | NCT00004097 | Head and Neck C... | fluorouracil gemcitabine hyd... paclitaxel radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer | NCT00003777 | Head and Neck C... | amifostine trih... cisplatin fluorouracil surgical proced... radiation thera... | 18 Years - 120 Years | Abramson Cancer Center at Penn Medicine | |
| EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma | NCT00004261 | Breast Cancer Cervical Cancer Head and Neck C... Prostate Cancer Sarcoma | EF5 flow cytometry fluorescent ant... immunohistochem... biopsy | 18 Years - 120 Years | University Health Network, Toronto | |
| Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer | NCT00003251 | Drug/Agent Toxi... Head and Neck C... Radiation Toxic... | amifostine trih... cisplatin paclitaxel radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer | NCT00003327 | Head and Neck C... | paclitaxel | 18 Years - | National Cancer Institute (NCI) | |
| Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors | NCT01172028 | Breast Cancer Esophageal Canc... Gastric Cancer Head and Neck C... Lung Cancer Ovarian Cancer Prostate Cancer | Taxotere (Docet... Alimta (Pemetre... | 18 Years - | University of Arizona | |
| Effects of Swallowing Exercises on Patients Undergoing Radiation Treatment for Head and Neck Cancer | NCT01053546 | Head and Neck C... Stage I Hypopha... Stage I Larynge... Stage I Orophar... Stage II Hypoph... Stage II Laryng... Stage II Oropha... Stage III Hypop... Stage III Laryn... Stage III Oroph... Stage IV Hypoph... Stage IV Laryng... Stage IV Oropha... | exercise interv... questionnaire a... quality-of-life... | 18 Years - | Wake Forest University Health Sciences | |
| Effects of Swallowing Exercises on Patients Undergoing Radiation Treatment for Head and Neck Cancer | NCT01053546 | Head and Neck C... Stage I Hypopha... Stage I Larynge... Stage I Orophar... Stage II Hypoph... Stage II Laryng... Stage II Oropha... Stage III Hypop... Stage III Laryn... Stage III Oroph... Stage IV Hypoph... Stage IV Laryng... Stage IV Oropha... | exercise interv... questionnaire a... quality-of-life... | 18 Years - | Wake Forest University Health Sciences | |
| Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors | NCT01172028 | Breast Cancer Esophageal Canc... Gastric Cancer Head and Neck C... Lung Cancer Ovarian Cancer Prostate Cancer | Taxotere (Docet... Alimta (Pemetre... | 18 Years - | University of Arizona | |
| EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma | NCT00004261 | Breast Cancer Cervical Cancer Head and Neck C... Prostate Cancer Sarcoma | EF5 flow cytometry fluorescent ant... immunohistochem... biopsy | 18 Years - 120 Years | University Health Network, Toronto | |
| Cisplatin and Gemcitabine in Treating Patients With Advanced Squamous Cell Cancer of the Head and Neck | NCT00003182 | Head and Neck C... | cisplatin gemcitabine hyd... | 18 Years - | National Cancer Institute (NCI) | |
| Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors | NCT00499291 | Cancer | paclitaxel albu... gene expression... laboratory biom... pharmacological... polymerase chai... | 18 Years - 120 Years | Eastern Cooperative Oncology Group |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
